Kim M Y, Choi N, Yang J-H, Yoo Y B, Park K S
Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, South Korea.
Department of Radiology, Konkuk University Medical Center, Konkuk University School of Medicine, South Korea.
Clin Radiol. 2015 Jul;70(7):706-10. doi: 10.1016/j.crad.2015.02.017. Epub 2015 Mar 29.
To investigate the relationship between mammographic breast density (MGD) and background parenchymal enhancement (BPE) at breast MRI and histopathological features of invasive breast cancers.
A total of 178 women with unilateral invasive breast cancer who preoperatively underwent mammography and breast MRI were included in the study. Two radiologists rated MGD and BPE according to BI-RADS criteria in consensus. The relationship between MGD and BPE was investigated, and compared with histopathological features of invasive breast cancers according to the level of MGD and BPE.
At MRI, there is no significant difference in the distribution of MGD and BPE of the contralateral breast in women with invasive breast cancer according to menopausal status (p=0.226, 0.384). Women with high MGD (>50% glandular) were more likely to have oestrogen-receptor (ER)-positive breast cancer (p=0.045) and progesterone receptor (PR)-positive breast cancer (p=0.020). With regard to BPE, PR positivity correlated with moderate or marked BPE with borderline significance (p=0.054). Multivariate logistic regression analyses revealed that women with high MGD were less likely to have triple-negative (i.e., a cancer that is ER negative, PR negative, and human epidermal growth factor receptor type 2 [HER2] negative) breast cancer compared with ER (+)/HER2 (-) cancer (OR=0.231, 95% CI: 0.070, 0.760; p=0.016). No association between the histological tumour characteristics and BPE was observed.
In women with invasive breast cancer, high MGD is associated with ER positivity of the invasive breast cancer. However, at MRI, BPE of the contralateral breast seems to be independent of tumour characteristics.
探讨乳腺钼靶密度(MGD)与乳腺磁共振成像(MRI)背景实质强化(BPE)之间的关系以及浸润性乳腺癌的组织病理学特征。
本研究纳入了178例术前接受乳腺钼靶检查和乳腺MRI检查的单侧浸润性乳腺癌女性患者。两名放射科医生根据BI-RADS标准对MGD和BPE进行了一致评级。研究了MGD与BPE之间的关系,并根据MGD和BPE水平与浸润性乳腺癌的组织病理学特征进行比较。
在MRI检查中,根据绝经状态,浸润性乳腺癌女性对侧乳腺的MGD和BPE分布无显著差异(p = 0.226,0.384)。MGD高(腺体>50%)的女性更有可能患雌激素受体(ER)阳性乳腺癌(p = 0.045)和孕激素受体(PR)阳性乳腺癌(p = 0.020)。关于BPE,PR阳性与中度或显著BPE相关,具有临界显著性(p = 0.054)。多因素逻辑回归分析显示,与ER(+)/HER2(-)癌症相比,MGD高的女性患三阴性(即ER阴性、PR阴性和人表皮生长因子受体2型[HER2]阴性)乳腺癌的可能性较小(OR = 0.231,95%CI:0.070,0.760;p = 0.016)。未观察到组织学肿瘤特征与BPE之间的关联。
在浸润性乳腺癌女性中,高MGD与浸润性乳腺癌的ER阳性相关。然而,在MRI检查中,对侧乳腺的BPE似乎与肿瘤特征无关。